VRG THERAPEUTICS IS A LEADER IN PHARMA R&D WITH WORLD-CLASS PLATFORMS TO CREATE PROTEINS AND
PEPTIDES TO BE UTILIZED IN CGT APPLICATIONS
Our mission is to cure diseases via targets and mechanism of actions (MoAs) that cannot be
reached with traditional approaches.
Using our unique ISEPTM and CREATeTM platforms, we optimize peptides and proteins of artificial
and natural origin using directed evolution to create peptide-based pharmaceuticals or
cutting-edge cell and gene therapy (CGT) products. The directed evolution platforms provide the
essence of our peptide/protein-based projects and enable us to handle a diverse portfolio,
hence ensure the long-term stability of our R&D activities. Whereas on the fundamentally
different parts of our projects, we cooperate with companies or academic laboratories having
outstanding expertise on the subject.